Skip to main content

and
  1. Article

    Open Access

    Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes – contraindications and opportunities

    Pharmacological inhibition of the renin-angiotensin-aldosterone-system (RAASi) is the cornerstone of hypertension treatment, renoprotection and secondary prevention of cardiovascular disease in patients with t...

    C. M. Gant, M. M. Oosterwijk, S. H. Binnenmars, G. J. Navis, H. Haverkate in BMC Nephrology (2023)

  2. Article

    Correction to: Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study

    The values given for copeptin levels in men in quartiles 1 and 2 (Table 1) were incorrect, and should have read.

    A. Abbasi, E. Corpeleijn, E. Meijer, D. Postmus, R. T. Gansevoort in Diabetologia (2019)

  3. Article

    Open Access

    Trajectories of metabolic risk factors and biochemical markers prior to the onset of type 2 diabetes: the population-based longitudinal Doetinchem study

    Risk factors often develop at young age and are maintained over time, but it is not fully understood how risk factors develop over time preceding type 2 diabetes. We examined how levels and trajectories of met...

    G Hulsegge, A M W Spijkerman, Y T van der Schouw, S J L Bakker in Nutrition & Diabetes (2017)

  4. No Access

    Article

    Effects of sodium and potassium supplementation on blood pressure and arterial stiffness: a fully controlled dietary intervention study

    We performed a randomised, placebo-controlled, crossover study to examine the effects of sodium and potassium supplementation on blood pressure (BP) and arterial stiffness in untreated (pre)hypertensive indivi...

    L Gijsbers, J I Dower, M Mensink, E Siebelink in Journal of Human Hypertension (2015)

  5. No Access

    Article

    Sex specific association between carnosinase gene CNDP1 and cardiovascular mortality in patients with type 2 diabetes (ZODIAC-22)

    Homozygosity for a 5-leucine repeat (5L-5L) in the carnosinase gene (CNDP1) has been associated with a reduced prevalence of diabetic nephropathy in cross-sectional studies in patients with type 2 diabetes, parti...

    A. Alkhalaf, G. W. D. Landman, K. J. J. van Hateren in Journal of Nephrology (2015)

  6. No Access

    Article

    Effect of a high-protein diet on maintenance of blood pressure levels achieved after initial weight loss: the DiOGenes randomized study

    Randomized trials have shown significant blood pressure (BP) reductions after increased protein compared with carbohydrate intake, but the effect on BP maintenance after initial weight loss is unclear. We exam...

    M F Engberink, J M Geleijnse, S J L Bakker, T M Larsen in Journal of Human Hypertension (2015)

  7. No Access

    Article

    Intake of total protein, plant protein and animal protein in relation to blood pressure: a meta-analysis of observational and intervention studies

    There is growing evidence from epidemiological studies that dietary protein may beneficially influence blood pressure (BP), but findings are inconclusive. We performed a meta-analysis of 29 observational studi...

    S M A J Tielemans, W Altorf-van der Kuil, M F Engberink in Journal of Human Hypertension (2013)

  8. Article

    Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33)

    Arginine vasopressin (AVP), the hormone important for maintaining fluid balance, has been shown to cause kidney damage in rodent models of diabetes. We investigated the potential role of AVP in the natural cou...

    W. E. Boertien, I. J. Riphagen, I. Drion, A. Alkhalaf, S. J. L. Bakker in Diabetologia (2013)

  9. Article

    A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus

    Microalbuminuria is considered the first clinical sign of kidney dysfunction and is associated with a poor renal and cardiovascular prognosis in type 2 diabetes. Detection of patients who are prone to develop ...

    S. S. Roscioni, D. de Zeeuw, M. E. Hellemons, H. Mischak, P. Zürbig in Diabetologia (2013)

  10. Article

    Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study

    Vasopressin plays a role in osmoregulation, glucose homeostasis and inflammation. Therefore, plasma copeptin, the stable C-terminal portion of the precursor of vasopressin, has strong potential as a biomarker ...

    A. Abbasi, E. Corpeleijn, E. Meijer, D. Postmus, R. T. Gansevoort in Diabetologia (2012)

  11. Article

    Plasma procalcitonin and risk of type 2 diabetes in the general population

    A. Abbasi, E. Corpeleijn, D. Postmus, R. T. Gansevoort, P. E. de Jong in Diabetologia (2011)

  12. Article

    Open Access

    A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus

    Homozygosity for a five leucine repeat (5L–5L) in the carnosinase gene (CNDP1) has been found to be cross-sectionally associated with a low frequency of diabetic nephropathy (DN), mainly in type 2 diabetes. We pr...

    A. Alkhalaf, S. J. L. Bakker, H. J. G. Bilo, R. O. B. Gans, G. J. Navis in Diabetologia (2010)

  13. Article

    Open Access

    Vitamin D as an accelerator of atherosclerotic calcification: a D-tail that may be a Trojan horse

    M. E. Hellemons, S. J. L. Bakker in Diabetologia (2010)

  14. Article

    Open Access

    Copper chelation as a potential treatment for left-ventricular hypertrophy in type 2 diabetes

    S. J. L. Bakker, G. Navis, R. O. B. Gans in Diabetologia (2009)

  15. Article

    Open Access

    Thiamine in diabetic nephropathy: a novel treatment modality?

    A. Alkhalaf, N. Kleefstra, K. H. Groenier, S. J. L. Bakker, G. J. Navis in Diabetologia (2009)

  16. Article

    Open Access

    Optimal dosing of renin–angiotensin–aldosterone system blockers for renal protection: a solved issue?

    G. D. Laverman, S. J. L. Bakker, G. J. Navis in Diabetologia (2009)

  17. Article

    35th Annual Meeting of the European Association for the Study of Diabetes

    A. Melander, J. Olsson, G. Lindberg, A. Salzman, T. Howard, P. Stang in Diabetologia (1999)

  18. Article

    The association of dietary fibres with glucose tolerance is partly explained by concomitant intake of thiamine: The Hoorn Study

    Epidemiologic studies have shown an association between the intake of dietary fibres and 2-h glucose values. Food rich in dietary fibres is often also rich in thiamine. Animal studies have shown that thiamine...

    S. J. L. Bakker, E. K. Hoogeveen, G. Nijpels, P. J. Kostense, J. M. Dekker in Diabetologia (1998)